Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maruhn

Showing results (71-80 of 89) with videos related to

Pageof 9
Sort By:
Physical Review Letters|August 7, 2007
From self-consistent covariant effective field theories to their galilean-invariant counterpartsA Sulaksono, P-G Reinhard, T J Bürvenich, et al.
FEBS Letters|July 4, 1983
Use of monoclonal and polyclonal antibodies as structural and topographical probes for hepatic epoxide hydrolaseC R Wolf, F Oesch, C Timms, et al.
Accident; Analysis and Prevention|February 4, 2021
Analysis of Street-Crossing Behavior: Comparing a CAVE Simulator and a Head-Mounted Display among Younger and Older AdultsPrashant Pala, Viola Cavallo, Nguyen Thong Dang, et al.
International Journal of Clinical Pharmacology and Therapeutics|July 31, 2009
Randomized, crossover, single-blind, placebo-controlled, human pharmacology clinical trial with desoxypeganine, a new cholinesterase and selective MAO-A inhibitor: multiple-dose pharmacokineticsJ Algorta, M A Pena, A Alvarez, et al.
Thrombosis and Haemostasis|May 6, 1998
Polymorphism of platelet membrane glycoprotein IIIa: human platelet antigen 1b (HPA-1b/PlA2) is an inherited risk factor for premature myocardial infarction in coronary artery diseaseR B Zotz, B R Winkelmann, M Nauck, et al.
Methods and Findings in Experimental and Clinical Pharmacology|June 19, 2008
Phase I clinical trial with desoxypeganine, a new cholinesterase and selective MAO-A inhibitor: tolerance and pharmacokinetics study of escalating single oral dosesJ Algorta, M A Pena, C Maraschiello, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|May 27, 2008
Are prothrombotic variants of platelet glycoprotein receptor polymorphisms involved in the pathogenesis of thrombotic microangiopathies?Christoph Sucker, Michael Schmitz, Gerd R Hetzel, et al.
Zentralblatt Fur Bakteriologie, Mikrobiologie Und Hygiene. 1. Abt. Originale B, Hygiene|January 1, 1982
Comparison of the morphological alteration and disintegration test (MADT) and the chimpanzee infectivity test for determination of hepatitis B virucidal activity of chemical disinfectantsO Thraenhart, E K Kuwert, N Scheiermann, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|September 27, 2007
The homozygous leu variant of the factor XIII Val34Leu polymorphism as a risk factor for the manifestation of thrombotic microangiopathiesChristoph Sucker, Firuseh Farokhzad, Christine Kurschat, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|May 19, 2009
The TT genotype of the C677T polymorphism in the methylentetrahydrofolate reductase as a risk factor in thrombotic microangiopathies: results from a pilot studyChristoph Sucker, Christine Kurschat, Firuseh Farokhzad, et al.
Pageof 9

Showing results (71-80 of 89) with videos related to

Sort By:
Pageof 9
Physical Review Letters|August 7, 2007
From self-consistent covariant effective field theories to their galilean-invariant counterpartsA Sulaksono, P-G Reinhard, T J Bürvenich, et al.
FEBS Letters|July 4, 1983
Use of monoclonal and polyclonal antibodies as structural and topographical probes for hepatic epoxide hydrolaseC R Wolf, F Oesch, C Timms, et al.
Accident; Analysis and Prevention|February 4, 2021
Analysis of Street-Crossing Behavior: Comparing a CAVE Simulator and a Head-Mounted Display among Younger and Older AdultsPrashant Pala, Viola Cavallo, Nguyen Thong Dang, et al.
International Journal of Clinical Pharmacology and Therapeutics|July 31, 2009
Randomized, crossover, single-blind, placebo-controlled, human pharmacology clinical trial with desoxypeganine, a new cholinesterase and selective MAO-A inhibitor: multiple-dose pharmacokineticsJ Algorta, M A Pena, A Alvarez, et al.
Thrombosis and Haemostasis|May 6, 1998
Polymorphism of platelet membrane glycoprotein IIIa: human platelet antigen 1b (HPA-1b/PlA2) is an inherited risk factor for premature myocardial infarction in coronary artery diseaseR B Zotz, B R Winkelmann, M Nauck, et al.
Methods and Findings in Experimental and Clinical Pharmacology|June 19, 2008
Phase I clinical trial with desoxypeganine, a new cholinesterase and selective MAO-A inhibitor: tolerance and pharmacokinetics study of escalating single oral dosesJ Algorta, M A Pena, C Maraschiello, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|May 27, 2008
Are prothrombotic variants of platelet glycoprotein receptor polymorphisms involved in the pathogenesis of thrombotic microangiopathies?Christoph Sucker, Michael Schmitz, Gerd R Hetzel, et al.
Zentralblatt Fur Bakteriologie, Mikrobiologie Und Hygiene. 1. Abt. Originale B, Hygiene|January 1, 1982
Comparison of the morphological alteration and disintegration test (MADT) and the chimpanzee infectivity test for determination of hepatitis B virucidal activity of chemical disinfectantsO Thraenhart, E K Kuwert, N Scheiermann, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|September 27, 2007
The homozygous leu variant of the factor XIII Val34Leu polymorphism as a risk factor for the manifestation of thrombotic microangiopathiesChristoph Sucker, Firuseh Farokhzad, Christine Kurschat, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|May 19, 2009
The TT genotype of the C677T polymorphism in the methylentetrahydrofolate reductase as a risk factor in thrombotic microangiopathies: results from a pilot studyChristoph Sucker, Christine Kurschat, Firuseh Farokhzad, et al.
Pageof 9